Viewing StudyNCT00230529



Ignite Creation Date: 2024-05-05 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00230529
Status: COMPLETED
Last Update Posted: 2011-06-09
First Post: 2005-09-29

Brief Title: A Safety and Efficacy Study of Infliximab Remicade in Patients With Plaque Type Psoriasis
Sponsor: Centocor Inc
Organization: Centocor Inc

Conditions & Keywords Data

Conditions:
Name
Psoriasis
Keywords:
Name View
biologics View
Plaque-type Psoriasis View
infliximab View
Remicade View